Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Gancotamab (Synonyms: MM-302, MM302)

Catalog No. T77017 Copy Product Info
🥰Excellent
Gancotamab (MM-302) is a HER2-targeting polyethylene glycolated liposome that encapsulates adriamycin to facilitate delivery to HER2-overexpressing tumor cells while limiting exposure to non-target tissues, including the heart.Gancotamab has antitumor activity and may be used to study advanced HER2-positive breast cancer.

Gancotamab

Copy Product Info
🥰Excellent
Catalog No. T77017
Synonyms MM-302, MM302

Gancotamab (MM-302) is a HER2-targeting polyethylene glycolated liposome that encapsulates adriamycin to facilitate delivery to HER2-overexpressing tumor cells while limiting exposure to non-target tissues, including the heart.Gancotamab has antitumor activity and may be used to study advanced HER2-positive breast cancer.

Gancotamab
Cas No. 1509928-00-0
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$163In StockIn Stock
5 mg$428In StockIn Stock
10 mg$679-In Stock
25 mg$987-In Stock
50 mg$1,380-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:96.7% (SDS-PAGE); 98.4% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Gancotamab (MM-302) is a HER2-targeting polyethylene glycolated liposome that encapsulates adriamycin to facilitate delivery to HER2-overexpressing tumor cells while limiting exposure to non-target tissues, including the heart.Gancotamab has antitumor activity and may be used to study advanced HER2-positive breast cancer.
In vitro
Gancotamab is a liposomal drug targeting HER2 that carries approximately 20,000 Doxorubicin molecules in its core and 45 single-chain anti-HER2 antibodies attached to its surface. [1]
Gancotamab (0.5 μM; 72 hr treatment) promotes increased mortality in BT474-M3 and NCI-N87 cells. [1]
Gancotamab (1 μM; 2-24 hrs) induces activation of p-p53 levels in BT474-M3 and NCI-N87 cells, but has no significant effect on p-Akt signaling. [1]
In vivo
Gancotamab (3 mg/kg; i.v. every 7 days; 3 doses) has a significant inhibitory effect on tumor growth and upregulates the expression of p-p53, a DNA damage marker. [1]
SynonymsMM-302, MM302
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetERBB2/HER2/CD340
Chemical Properties
Molecular Weight25.79 kDa
Cas No.1509928-00-0
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Gancotamab | purchase Gancotamab | Gancotamab cost | order Gancotamab | Gancotamab in vivo | Gancotamab in vitro | Gancotamab molecular weight